Clinical Trials Directory

Trials / Completed

CompletedNCT02743091

Idiopathic Pre-capillary Pulmonary Hypertension in ESKD Patients

Idiopathic Pre-capillary Pulmonary Hypertension in Patients With End-stage Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
1,988 (actual)
Sponsor
Toujinkai Hospital · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study investigates the prevalence and prognosis of idiopathic pre-capillary pulmonary hypertension (PH) in patients with end-stage kidney disease (ESKD).

Detailed description

Pulmonary hypertension (PH) is a rare cardiovascular disease with progressive and fatal features. PH is classified into the 5 groups, and the prevalence of group 1 pulmonary arterial hypertension, including idiopathic and heritable, is 5 to 15 cases per one million adults and a median survival was reportedly three years. PH found in patients with end-stage kidney disease (ESKD) is classified into group 5, because the pathogenesis and clinical characteristics have not been clarified. The prevalence of PH in patients with ESKD was reportedly around 17\~56% based on echocardiographic studies. In this study, we evaluated the incidence of idiopathic pre-capillary PH of ESKD patients by right heart catheterization, and examined the prognosis by following the occurrence of heart failure death.

Conditions

Timeline

Start date
2001-01-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2016-04-19
Last updated
2016-04-19

Source: ClinicalTrials.gov record NCT02743091. Inclusion in this directory is not an endorsement.